Non-executive Director & Chair Designate
Appointment of Non-executive Director and Chair Designate
Aggreko plc is pleased to announce the appointment of Mark Clare as a Non-executive Director and Chair Designate with effect from 1 October 2020.
Subject to shareholder approval of his election to the Board, Mark will become Chair of the Board following our 2021 Annual General Meeting. This will allow for a managed and orderly transition from the current Chairman, Ken Hanna. Ken will step down as Chairman and Non-executive Director at the conclusion of the 2021 Annual General Meeting (as stated in our Interim Results announcement of 6 August 2020).
Mark is currently Chair of Grainger plc, Senior Independent Director of United Utilities Group plc and a Non-executive Director of Premier Marina Holdings Limited. He was also Senior Independent Director of Ladbrokes Coral Group plc from 2016-2018 and a Non-executive Director of BAA plc from 2001-2006. Mark was previously Chief Executive of Barratt Developments plc from 2006-2015. Prior to joining Barratt, he held a number of senior roles within Centrica plc and British Gas plc.
Mark will join the Nomination, Remuneration and Ethics & Corporate Responsibility Committees.
Uwe Krueger, the Company's Senior Independent Director who led the planned succession process, said:
"We are delighted to welcome Mark to the Board. Mark's appointment to the Board as Non-executive Director and Chair Designate reflects his calibre and suitability for the role of leading the Aggreko Board. He is an experienced Non-executive Director and Chair, bringing a wealth of industry knowledge, strong leadership track record, extensive knowledge of customer needs and market leading service levels. We look forward to working with Mark."
This disclosure is made pursuant to paragraph 9.6.13(R) of the Listing Rules.
Telephone: 0141 225 5900
6 August 2020
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.